Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Thomas Jefferson University (23)
- LSU Health New Orleans (5)
- Rowan University (4)
- Old Dominion University (3)
- Advocate Health - Midwest (2)
-
- City University of New York (CUNY) (2)
- Loma Linda University (2)
- University of Arkansas, Fayetteville (2)
- University of Connecticut (2)
- Aga Khan University (1)
- American University in Cairo (1)
- Arcadia University (1)
- Belmont University (1)
- Chapman University (1)
- JSS Academy of Higher Education and Research (1)
- Liberty University (1)
- Lincoln Memorial University (1)
- Marshall University (1)
- Nova Southeastern University (1)
- St. John Fisher University (1)
- The University of Southern Mississippi (1)
- University of Central Florida (1)
- University of Mary Washington (1)
- University of Nebraska - Lincoln (1)
- University of Nebraska Medical Center (1)
- University of Texas at Arlington (1)
- Virginia Commonwealth University (1)
- Keyword
-
- Humans (16)
- Male (14)
- Middle Aged (13)
- Female (12)
- Aged (11)
-
- Middle aged (11)
- Biomarkers (10)
- Adult (8)
- Prognosis (5)
- Tumor (5)
- Biomarkers, Tumor (4)
- Chemotherapy (4)
- Prospective Studies (4)
- Prospective studies (4)
- Prostatic neoplasms (4)
- Chronic disease (3)
- Gene Expression Regulation, Neoplastic (3)
- Gene expression regulation (3)
- Heart failure (3)
- Immunotherapy (3)
- Ischemia (3)
- Neoplastic (3)
- Predictive Value of Tests (3)
- Predictive value of tests (3)
- Prostatic Neoplasms (3)
- Risk Assessment (3)
- Risk Factors (3)
- Risk assessment (3)
- Risk factors (3)
- Young adult (3)
- Publication Year
- Publication
-
- School of Medicine Faculty Publications (4)
- Rowan-Virtua Research Day (3)
- Wills Eye Hospital Papers (3)
- Abington Jefferson Health Papers (2)
- Department of Dermatology and Cutaneous Biology Faculty Papers (2)
-
- Department of Emergency Medicine Faculty Papers (2)
- Department of Pathology, Anatomy, and Cell Biology Faculty Papers (2)
- Department of Surgery Faculty Papers (2)
- Dissertations, Theses, and Capstone Projects (2)
- Journal of Patient-Centered Research and Reviews (2)
- Kimmel Cancer Center Faculty Papers (2)
- Loma Linda University Electronic Theses, Dissertations & Projects (2)
- Bioengineering Dissertations - Archive (1)
- Biological Sciences Undergraduate Honors Theses (1)
- Capstone Showcase (1)
- Chemistry & Biochemistry Undergraduate Honors Theses (1)
- Department of Chemical and Biomolecular Engineering: Dissertations, Theses, and Student Research (1)
- Department of Medical Oncology Faculty Papers (1)
- Department of Medicine Faculty Publications (1)
- Department of Neurology Faculty Papers (1)
- Department of Obstetrics & Gynecology Faculty Publications (1)
- Department of Otolaryngology (ENT) Faculty Publications (1)
- Department of Otolaryngology - Head and Neck Surgery Faculty Papers (1)
- Department of Pathology and Laboratory Medicine (1)
- Department of Pediatrics Faculty Papers (1)
- Departmental Honors & Graduate Capstone Projects (1)
- Digital Journal of Clinical Medicine (1)
- Division of Cardiology Faculty Papers (1)
- Doctoral Projects (1)
- Einstein Health Papers (1)
- Publication Type
Articles 61 - 63 of 63
Full-Text Articles in Biological Factors
Production Of Recombinant Human Coagulation Factor Ix By Transgenic Pig, Weijie Xu
Production Of Recombinant Human Coagulation Factor Ix By Transgenic Pig, Weijie Xu
Department of Chemical and Biomolecular Engineering: Dissertations, Theses, and Student Research
Hemophilia B is the congenital bleeding disorder caused by deficiency in functional coagulation factor IX (FIX) and about 28,000 patients worldwide in 2012. And current treatment is restricted to protein-replacement therapy, which required FIX concentrates for patients’ life-time. Approximately 1 billion units FIX were consumed in 2012. However, still about 70-80% patients, mostly in developing countries, received inadequate or no treatment because of the unavailable and/or unaffordable FIX concentrates. Considering safety reasons, e.g. transmission of blood-borne diseases, the recombinant human FIX (rFIX) is recommended other than the plasma-derived FIX. However, only one rFIX is currently available on the market. The …
The Morbidity & Mortality Of Prevalent Heart Failure, Jennifer Kwon
The Morbidity & Mortality Of Prevalent Heart Failure, Jennifer Kwon
Loma Linda University Electronic Theses, Dissertations & Projects
The first study population included 292 unselected consecutive patients from the LLUMC heart failure clinic who were enrolled in the study from January to July 2006 and were followed up through the end of December 2010. The treatment policy at the clinic was to uptitrate dosages of beta-adrenergic blockade (β-blockers), angiotensin-converting-enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) to the most tolerable levels in order to reach target dosages, as recommended by the Heart Failure Society of America (HFSA). Patients were classified into systolic heart failure (ejection fraction (EF) < 40%) or diastolic heart failure (EF≥40%). All dosages of β-blockers, ACEi and ARB were extracted through chart reviews and were used as the main predictors of the patients' survival. Results from analyses showed that reaching target dosages of β-blockers and ACEi/ARB may increase survival when compared to not reaching target among the systolic HF population (HRβ_biockers= 0.64, 95% CI 0.26-1.56 and HRACEi/ARB=0.50, …
Relationship Of Vitamin D Levels To Blood Pressure In A Biethnic Cohort, Rosario O. Sakamoto
Relationship Of Vitamin D Levels To Blood Pressure In A Biethnic Cohort, Rosario O. Sakamoto
Loma Linda University Electronic Theses, Dissertations & Projects
Background: Serum hydroxyvitamin D [25(OH)D] has been well-accepted as not an ordinary vitamin but a pro-hormone that has many benefits beyond its well-known effects on bone. Cardiovascular risk factors such as hypertension remain a huge health burden and Blacks have been recognized to have higher prevalence of hypertension compared to non-Hispanic Whites. Despite increasing evidence of the benefits of vitamin D on blood pressure control, there is much more to be learned about the relationship of serum 25(OH)D to blood pressure among different ethnicities.
Purpose: The goal of this study was to determine whether vitamin D serum 25(OH)D levels were …